GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » Market Cap

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Market Cap : RM57.63 Mil (As of May. 25, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Malaysian Genomics Resource Centre Bhd's share price for the quarter that ended in Sep. 2023 was RM0.47. Malaysian Genomics Resource Centre Bhd's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 137.21 Mil. Therefore, Malaysian Genomics Resource Centre Bhd's market cap for the quarter that ended in Sep. 2023 was RM64.49 Mil.

Malaysian Genomics Resource Centre Bhd's quarterly market cap declined from Dec. 2022 (RM99.61 Mil) to Mar. 2023 (RM76.17 Mil) and declined from Mar. 2023 (RM76.17 Mil) to Sep. 2023 (RM64.49 Mil).

Malaysian Genomics Resource Centre Bhd's annual market cap increased from Jun. 2019 (RM32.09 Mil) to Jun. 2020 (RM36.23 Mil) and increased from Jun. 2020 (RM36.23 Mil) to Jun. 2021 (RM176.58 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Malaysian Genomics Resource Centre Bhd's Enterprise Value for Today is RM58.18 Mil.


Malaysian Genomics Resource Centre Bhd Market Cap Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd Market Cap Chart

Malaysian Genomics Resource Centre Bhd Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.61 24.84 32.09 36.23 176.58

Malaysian Genomics Resource Centre Bhd Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 107.44 92.45 99.61 76.17 64.49

Competitive Comparison of Malaysian Genomics Resource Centre Bhd's Market Cap

For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Malaysian Genomics Resource Centre Bhd's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's Market Cap distribution charts can be found below:

* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's Market Cap falls into.



Malaysian Genomics Resource Centre Bhd Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Malaysian Genomics Resource Centre Bhd's Market Cap for the fiscal year that ended in Jun. 2021 is calculated as

Market Cap (A: Jun. 2021 )=Share Price (A: Jun. 2021 )*Shares Outstanding (EOP) (A: Jun. 2021 )
=RM1.49*118.51
=RM176.58

Malaysian Genomics Resource Centre Bhd's Market Cap for the quarter that ended in Sep. 2023 is calculated as

Market Cap (Q: Sep. 2023 )=Share Price (Q: Sep. 2023 )*Shares Outstanding (EOP) (Q: Sep. 2023 )
=RM0.47*137.21
=RM64.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Malaysian Genomics Resource Centre Bhd  (XKLS:0155) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Malaysian Genomics Resource Centre Bhd Market Cap Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Malaysian Genomics Resource Centre Bhd (XKLS:0155) Business Description

Traded in Other Exchanges
N/A
Address
8F, Jalan Teknologi 3/6, Taman Sains, Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) services, genetic screening services (GSS), and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtect which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of its revenue from Pathology services.

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Headlines

No Headlines